Skip to main content
Log in

Primärtherapie des Analkarzinoms

Primary treatment of anal cancer

  • Chirurgie und Recht
  • Published:
Der Chirurg Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii10–iii20

    Article  PubMed  Google Scholar 

  2. Salati SA, Al Kadi A (2012) Anal cancer – a review. Int J Health Sci (qassim) 6(2):206–230

    Article  Google Scholar 

  3. Garrett K, Kalady MF (2010) Anal neoplasms. Surg Clin North Am 90(1):147–161

    Article  PubMed  Google Scholar 

  4. Fraunholz I, Woeste G, Hofheinz RD (2014) Therapie des Analkarzinoms. Onkologe 20(2):173–182

    Article  Google Scholar 

  5. Nigro ND, Vaitkevicius VK, Considine B Jr. (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356

    Article  CAS  PubMed  Google Scholar 

  6. National Comprehensive Cancer Network NCCN (2017) Clinical practice guidelines in oncology, anal carcinoma. Version I. http://www.nccn.org (Erstellt: 23. Nov. 2016). Zugegriffen: 22. Jan. 2017

    Google Scholar 

  7. Deutsche Aids-Gesellschaft e. V. (DAIG) (2013) Deutsch-Österreichische Leitlinie: Anale Dysplasien und Analkarzinome bei HIV-Infizierten: Prävention, Diagnostik, Therapie. http://www.awmf.org/uploads/tx_szleitlinien/055-007l_S1k_Anale_Dysplasien_Analkarzinom_HIV_infizierten_09-2013__01.pdf. Zugegriffen: 8. Apr. 2016

    Google Scholar 

  8. James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14(6):516–524

    Article  CAS  PubMed  Google Scholar 

  9. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914–1921

    Article  CAS  PubMed  Google Scholar 

  10. Peiffert D, Tournier-Rangeard L, Gérard JP, Lemanski C, François E, Giovannini M, Cvitkovic F, Mirabel X, Bouché O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-Lévi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30(16):1941–1948

    Article  CAS  PubMed  Google Scholar 

  11. Glynne-Jones R, Saleem W, Harrison M, Mawdsley S, Hall M (2016) Background and current treatment of squamous cell carcinoma of the anus. Oncol Ther 4(2):135–172

    Article  PubMed  PubMed Central  Google Scholar 

  12. Harris DA, Williamson J, Davies M, Evans MD, Drew P, Beynon J, Swansea Pelvic Oncology Group (2013) Outcome of salvage surgery for anal squamous cell carcinoma. Colorectal Dis 15(8):968–973

    Article  CAS  PubMed  Google Scholar 

  13. NCCN (2017) Guidlines version 2/2017 anal carcinoma. www.nccn.org/professionals/physician_gls/PDF/anal.pdf. Zugegriffen: 15. Nov. 2017

    Google Scholar 

  14. Siewert JR, Rothmund M, Schumpelick V (2010) Praxis der Viszeralchirurgie. Onkologische Chirurgie. In: Zimmermann F, Tympner Ch (Hrsg) Analkarzinom, 3. Aufl. Springer, Berlin, Heidelberg, S 735–731

    Google Scholar 

  15. Raptis D, Scheider I, Matzel KE, Ott O, Fietkau R, Hohenberger W (2015) Differenzialdiagnose und interdisziplinäre Therapie des Analkarzinoms. Dtsch Arztebl 112(14):243–248

    Google Scholar 

  16. Otto SD, Lee L, Buhr HJ et al (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 13:1292–1298

    Article  CAS  PubMed  Google Scholar 

  17. Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer. ESMO-ESSO-ESTRO clinical practice guidelines fpr diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):10–20

    Article  Google Scholar 

  18. Harris DA, Williamson J, Davies M, Evans MD, Drew P, Beynon J, Swansea Pelvic Oncology Group (2013) Outcome of salvage surgery for anal squamous cell carcinoma. Colorectal Dis 15(8):68–73

    Article  Google Scholar 

  19. Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to H. Dralle, K. Kols, H. Witzigmann or R. Viebahn.

Ethics declarations

Interessenkonflikt

H. Dralle, K. Kols, H. Witzigmann und R. Viebahn geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dralle, H., Kols, K., Witzigmann, H. et al. Primärtherapie des Analkarzinoms. Chirurg 89, 152–154 (2018). https://doi.org/10.1007/s00104-017-0573-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-017-0573-2

Navigation